Intranasal Arc-engineered exosomes reduce Alzheimer pathology by restoring autophagy
The targeted nanoplatform cleared amyloid deposits and suppressed neuroinflammation in an Alzheimer's model by inhibiting mTOR signaling.
Nanomedicine : nanotechnology, biology, and medicine · Sun C et al. · Paper published 25 Sep 2026
In an animal model of Alzheimer's disease, intranasal delivery of neural stem cell-derived exosomes engineered with the scaffolding protein Arc reduced key disease signs. Researchers first analyzed 143,214 single nuclei, identifying excitatory neurons as the main site of cellular damage marked by disrupted proteostasis and autophagy pathways. To counter these deficits, the team engineered exosomes to overexpress Arc, leveraging its natural neuronal affinity and neurorestorative actions. Following intranasal administration, the Arc-engineered exosomes accumulated efficiently in the central nervous system. The treatment significantly lowered beta-amyloid deposition, dampened neuroinflammation, and repaired injured neurons. Mechanistic analysis showed that these engineered exosomes restored cellular homeostasis by suppressing mTOR signaling and reactivating autophagy.
Why it matters
Loss of proteostasis and impaired autophagy are central drivers of brain aging and neurodegeneration. Using targeted nanoplatforms to re-engage these cellular cleanup pathways provides a targeted strategy to protect vulnerable neurons.
Caveats
The findings are restricted to an animal model and cannot be directly translated to human patients without clinical testing. In addition, the abstract does not report sample sizes, specific cognitive metrics, or long-term safety data.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Targeting neuronal injury with intranasal Arc-engineered exosomes rescues cognitive deficits in Alzheimer's disease via the mTOR-autophagy pathway
Sun C, Sha S, Kang J et al.
Nanomedicine : nanotechnology, biology, and medicine · 25 Sep 2026 · Peer-reviewed
- Relevance
- Relevant
- News value
- Notable
- Evidence
- Animals
- Status
- Peer-reviewed
More on Brain aging
See allHuman neurons accumulate far more mutations over lifespan than shorter-lived mammals
Cortical neurons gain mutations at similar yearly rates across six species, leaving aged humans with uniquely high mutational burdens and transcriptomic dysregulation.
bioRxiv : the preprint server for biology · Caglayan E et al.
CAR T cells targeting inflammatory bone marrow progenitors restore cognition in aged mice
Clearing these peripheral myeloid cells remodeled brain macrophages and improved cognitive performance without requiring the engineered immune cells to enter the brain.
bioRxiv · Harris AS et al.
Extracellular cGAMP drives neuroinflammation and premature aging phenotypes in mice
Loss of the cGAMP-degrading enzyme ENPP1 allows microglia-derived signaling molecules to trigger STING-dependent inflammation across multiple brain cell types.
bioRxiv · R. Carvalho D et al.
Directly converted human neuronal spheroids preserve donor age and model Alzheimer disease
The three-dimensional cell platform maintains biological aging markers while spontaneously developing hallmark pathologies of sporadic Alzheimer disease.
bioRxiv · Alsolami S et al.
Auditory nerve myelin degeneration defines a subtype of age-related hearing loss
Researchers linked poor auditory nerve synchrony and myelin degradation to amplified communication difficulties in older humans, beyond standard hearing thresholds.
medRxiv : the preprint server for health sciences · Harris KC et al.